Strengthening Causal Inference with Sensitivity Analyses: Using the Bayesian Parametric G-Formula

2 minute read

Published: February 19th, 2025

Understanding causal relationships in real-world data is challenging, particularly in observational studies, where confounding can introduce bias. If confounding is not properly accounted for, treatment effect estimates may be misleading, impacting decision-making.

Therefore, correctly modelling confounding is essential for valid causal inferences. Two popular approaches to achieve this are inverse probability of treatment weighting (IPTW) and the parametric g-formula. Both methods assume confounding has been adequately modelled. However, what if it is not?

Historically, this is listed as a limitation. In recent years, sensitivity analyses have become increasingly popular to better understand this assumption. This webinar will focus on using the Bayesian parametric g-formula as a sensitivity analysis for measured confounding. Prior information about confounders can be incorporated into the model. This allows for a better understanding of the range of the plausible effects. Various scenarios can also be considered including if the confounder is a weak confounder or strong confounder.

This approach offers a practical solution for researchers to ensure the validity of findings.

Learning Points:

  • How Bayesian methods improve sensitivity analyses
  • Incorporating prior knowledge about confounding
  • Practical applications for real-world data research

Watch this webinar recording and explore how the Bayesian Parametric G-Formula can be used as a sensitivity analysis tool to strengthen causal inference and improve the validity of findings.

Complete the form below to access the recording and slides.

Related articles

AI for Clinical Research Series – Prediction

AI for Clinical Research Series – Prediction

June 26th, 2026 1 minute read

Augmenting Clinical Trials with Synthetic or Simulated Patients, Projecting Long-Term Benefit-Risk, and Developing Re...

A Systematic Review into the Use of Bayesian Methods in Clinical Trials

A Systematic Review into the Use of Bayesian Methods in Clinical Trials

June 25th, 2026 2 minute read

Drug development in rare diseases requires the most efficient use of limited data, across both clinical trials and re...

AI for Automation and Digital Data Flow

AI for Automation and Digital Data Flow

June 24th, 2026 1 minute read

Automate Programming and QC Processes, Accelerating Operations and Evidence Generation This session will explore AI’s...